Darren Ji

Dr. Ji has served on the board of directors at Legend Biotech since May 2020. Dr. Ji is Chairman and CEO of Elpiscience Biopharmaceuticals, a clinical stage immunotherapy company that he co-founded. He is also a Venture Partner of Lilly Asia Ventures (LAV). Prior to that Dr. Ji was Global Head and Vice President of Roche for Business Development in Asia and Emerging Markets. In this role, Dr. Ji was responsible for driving the strategy and execution of business development activities in a large territory encompassing over 100 countries. During his tenure, Dr. Ji championed and oversaw the closing of a number of key transactions between Roche and partners worldwide. He managed a global team and established a strong business network in key countries including: China, Japan, Korea, Australia/New Zealand, Russia and Brazil.

A repeat entrepreneur himself, Dr. Ji started his career at the Procter & Gamble Pharmaceuticals with increasing responsibilities in drug R&D and business development. He co-founded and managed as CEO of PharmaLegacy Laboratories in Shanghai in 2008, which became a premium CRO providing high-quality drug discovery services to a large global clientele until today. Dr. Ji has been a highly respected leader and a sought-after speaker in global business forums. He was also an avid community builder exemplified by completing one of the longest services as a board member of the BayHelix Group, a community of business leaders of Chinese heritage in the life sciences.

Dr. Ji received his Doctor of Medicine from China Medical University, China; a Doctor of Philosophy degree from University of Sheffield, UK; and a Master of Business Administration degree from the University of Chicago, USA.